SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Astex Pharmaceuticals Announces Subcutaneous SGI-110 Interim Phase 1/2 MDS and AML Data Presentation at American Association for Cancer Research
Your Message